Astrana Health, Inc. (ASTH) — Institutional Holders, Q2 2026 (page 3)

210 institutional investment managers reported a ASTH position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $1.5B. Every filer is listed below, ranked by position value, 100 per page; this page shows ranks 201 to 210. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.

ASTH 13F holders ranked 201–210 of 210

Institutional investors reporting a position in Astrana Health, Inc. on SEC Form 13F-HR for Q2 2026, ranked by reported value.
InstitutionValueQoQ
JFS WEALTH ADVISORS#201 · 6 sh$279.00New
EverSource Wealth Advisors#202 · 6 sh$279.00-99.8%
Plante Moran Financial Advisors#203 · 6 sh$278.00New
GILPIN WEALTH MANAGEMENT#204 · 5 sh$233.00+400.0%
Davis Capital Management#205 · 2 sh$93.00New
Dunhill Financial#206 · 1 sh$56.000.0%
TFC Financial Management#207 · 1 sh$47.00New
Hughes Financial Services#208 · 1 sh$46.00New
Evolution Advisers#209 · 3 sh$0.00New
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM#210 · 51,049 sh—-0.6%

Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.